U.S. markets closed

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
37.40-0.12 (-0.32%)
At close: 4:00PM EST

37.52 +0.12 (0.32%)
After hours: 7:02PM EST

Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

Currency in GBP. All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
34,259,000
33,754,000
30,821,000
30,186,000
27,889,000
Cost of Revenue
11,781,000
11,863,000
10,241,000
10,342,000
9,290,000
Gross Profit
22,478,000
21,891,000
20,580,000
19,844,000
18,599,000
Operating Expense
14,523,000
15,599,000
13,516,000
13,783,000
12,573,000
Operating Income
7,955,000
6,292,000
7,064,000
6,061,000
6,026,000
Net Non Operating Interest Income Expense
-835,000
-840,000
-728,000
-667,000
-662,000
Pretax Income
7,858,000
6,221,000
4,800,000
3,525,000
1,939,000
Tax Provision
792,000
953,000
754,000
1,356,000
877,000
Net Income Common Stockholders
6,371,000
4,645,000
3,623,000
1,532,000
912,000
Diluted NI Available to Com Stockholders
6,371,000
4,645,000
3,623,000
1,532,000
912,000
Basic EPS
-
0.0019
0.0015
0
0
Diluted EPS
-
0.0019
0.0015
0
0
Basic Average Shares
-
2,473,500
2,457,000
2,443,000
2,430,000
Diluted Average Shares
-
2,508,000
2,485,500
2,470,500
2,454,500
Total Operating Income as Reported
8,624,000
6,961,000
5,483,000
4,087,000
2,598,000
Rent Expense Supplemental
-
29,000
205,000
119,000
99,000
Total Expenses
26,304,000
27,462,000
23,757,000
24,125,000
21,863,000
Net Income from Continuing & Discontinued Operation
6,371,000
4,645,000
3,623,000
1,532,000
912,000
Normalized Income
6,371,000
4,056,335
4,943,981
2,690,031
3,656,000
Interest Income
-
98,000
81,000
63,000
70,000
Interest Expense
832,000
885,000
771,000
736,000
717,000
Net Interest Income
-835,000
-840,000
-728,000
-667,000
-662,000
EBIT
8,690,000
7,106,000
5,571,000
4,261,000
2,656,000
EBITDA
8,690,000
-
-
-
-
Reconciled Cost of Revenue
11,781,000
11,863,000
10,241,000
10,342,000
9,290,000
Reconciled Depreciation
-468,000
2,334,000
1,856,000
1,922,000
1,774,000
Net Income from Continuing Operation Net Minority Interest
6,371,000
4,645,000
3,623,000
1,532,000
912,000
Total Unusual Items Excluding Goodwill
-
695,000
-1,567,000
-1,882,000
-3,430,000
Total Unusual Items
-
695,000
-1,567,000
-1,882,000
-3,430,000
Normalized EBITDA
8,690,000
8,745,000
8,994,000
8,065,000
7,860,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
106,335
-246,019
-723,969
-686,000